feed,title,long_url,short_url
Investing,"Seaport believes 'risk-reward in FUBO shares is attractive', upgrades rating",https://www.investing.com/news/stock-market-news/seaport-believes-riskreward-in-fubo-shares-is-attractive-upgrades-rating-93CH-3323142,https://da.gd/4jYfF
Investing,UBS raises eBay stock price target on 'potential return to GMV growth',https://www.investing.com/news/stock-market-news/ubs-raises-ebay-stock-price-target-on-potential-return-to-gmv-growth-93CH-3323141,https://da.gd/Rr9W8u
Investing,"Wolfe analysts: Market isn't in another TMT bubble, yet",https://www.investing.com/news/stock-market-news/wolfe-analysts-market-isnt-in-another-tmt-bubble-yet-432SI-3323132,https://da.gd/V1n6Wd
Investing,FDA grants breakthrough status to EDAP's endometriosis device,https://www.investing.com/news/stock-market-news/fda-grants-breakthrough-status-to-edaps-endometriosis-device-93CH-3323139,https://da.gd/zKHOA
Investing,Helius secures Medicare codes for MS gait therapy device,https://www.investing.com/news/stock-market-news/helius-secures-medicare-codes-for-ms-gait-therapy-device-93CH-3323138,https://da.gd/URiO
Investing,TriNet Group shares target raised to $140 by TD Cowen,https://www.investing.com/news/stock-market-news/trinet-group-shares-target-raised-to-140-by-td-cowen-93CH-3323135,https://da.gd/ok5l3
Investing,"Cigna stock maintains Overweight rating, $372 target",https://www.investing.com/news/stock-market-news/cigna-stock-maintains-overweight-rating-372-target-93CH-3323133,https://da.gd/owKtzk
Investing,ThredUp Earnings: What To Look For From TDUP,https://www.investing.com/news/stock-market-news/thredup-earnings-what-to-look-for-from-tdup-3323131,https://da.gd/vDcMyd
Investing,"Sea (NYSE:SE) Posts Better-Than-Expected Sales In Q4, Stock Jumps 12.6%",https://www.investing.com/news/stock-market-news/sea-nysese-posts-betterthanexpected-sales-in-q4-stock-jumps-126-3323121,https://da.gd/RdWl
Investing,Avidity advances Phase 3 trial for myotonic dystrophy treatment,https://www.investing.com/news/stock-market-news/avidity-advances-phase-3-trial-for-myotonic-dystrophy-treatment-93CH-3323120,https://da.gd/yYSmMN
